JAK inhibitors for the treatment of adult dermatomyositis: A pilot study-Reference-Cited by-同舟云学术

JAK inhibitors for the treatment of adult dermatomyositis: A pilot study

Published:2023-04 Issue:4 Volume:88 Page:924-926
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Landon-Cardinal Océane,Guillaume-Jugnot Perrine,Toquet Ségolène,Sbeih Nabiha,Rigolet Aude,Champtiaux Nicolas,Dorgham Karim,Gorochov Guy,Meyer Alain,Anquetil Céline,Barete Stéphane,Benveniste Olivier,Allenbach Yves

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis;Huard;Br J Dermatol,2017

2. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis;Ladislau;Brain J Neurol,2018

3. Study of tofacitinib in refractory dermatomyositis: an open-label pilot study of ten patients;Paik;Arthritis Rheumatol,2021

4. Tofacitinib as treatment for refractory dermatomyositis: a retrospective study from 2 academic medical centers;Min;J Am Acad Dermatol,2022

5. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis;Ytterberg;N Engl J Med,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons;Expert Opinion on Pharmacotherapy;2024-08-12

2. Effectiveness of generic tofacitinib in idiopathic inflammatory myositis (IIM)—a retrospective analysis from Indian Myositis Registry (MyoIN);Clinical Rheumatology;2024-06-03

3. Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis;Frontiers in Immunology;2024-03-21

4. Quoi de neuf en médecine interne ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12

5. A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons;Expert Review of Clinical Immunology;2023-10-17